Minority Views
[To accompany H.R. 801]
[Including cost estimate of the Congressional Budget Office]
The Committee on Energy and Commerce, to whom was referred
the bill (H.R. 801) to amend title III of the Public Health
Service Act to provide for suspension of entries and imports
from designated countries to prevent the spread of communicable
diseases and import into the United States of certain
controlled substances, having considered the same, reports
favorably thereon without amendment and recommends that the
bill do pass.
CONTENTS
Page
Purpose and Summary.............................................. 2
Background and Need for Legislation.............................. 2
Committee Action................................................. 2
Committee Votes.................................................. 2
Oversight Findings and Recommendations........................... 4
New Budget Authority, Entitlement Authority, and Tax Expenditures 4
Congressional Budget Office Estimate............................. 4
Federal Mandates Statement....................................... 5
Statement of General Performance Goals and Objectives............ 5
Duplication of Federal Programs.................................. 5
Related Committee and Subcommittee Hearings...................... 6
Committee Cost Estimate.......................................... 6
Earmark, Limited Tax Benefits, and Limited Tariff Benefits....... 6
Advisory Committee Statement..................................... 6
Applicability to Legislative Branch.............................. 6
Section-by-Section Analysis of the Legislation................... 6
Changes in Existing Law Made by the Bill, as Reported............ 7
Minority, Additional, or Dissenting Views........................ 9
Purpose and Summary
This bill allows the Secretary of the Department of Health
and Human Services, after consultation with the Attorney
General, to restrict the entry of persons or property from
foreign countries to prevent the introduction of certain
controlled substances into the United States.
Background and Need for Legislation
Currently, 42 U.S.C. 265 allows the Secretary, in the
interest of public health, to restrict the entry of persons or
property from certain designated countries when there is
serious danger of introduction of a communicable disease into
the United States.
The United States is facing an unprecedented illicit drug
crisis, and simultaneously suffering under skyrocketing
overdose and poisoning rates. This bill would expand the
current already existing authority under 42 U.S.C. 265 to allow
the Secretary, in the interest of public health, to restrict
the entry of persons or property from certain designated
countries when there is serious danger of introduction of a
communicable disease or, after consultation with the Attorney
General, certain controlled substances. The certain controlled
substances include, as defined in the corresponding Code of
Federal Regulations, narcotic drugs, opiates, opium
derivatives, stimulants, and fentanyl-related substances.
Committee Action
On February 15, 2023, the Subcommittees on Oversight and
Investigations and Health, jointly, held a hearing on H.R. 801.
The Subcommittee received testimony from:
Mr. Urbino Martinez, Brooks County Sheriff
Mr. Stuart Archer, CEO, Oceans Health Care
Ms. Rochelle M. Garza, President, Texas
Civil Rights Project
Mr. Brandon Judd, President, National Border
Patrol Council
On March 8, 2023, the Subcommittee on Health met in open
markup session and forwarded H.R. 801, without amendment, to
the full Committee by a recorded vote of 17 yeas and 12 nays.
On March 23 and 24, 2023, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 801,
without amendment, favorably reported to the House by a
recorded vote of 24 yeas and 19 nays.
Committee Votes
Clause 3(b) of rule XIII requires the Committee to list the
record votes on the motion to report legislation and amendments
thereto. The following reflects the record votes taken during
the Committee consideration:
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
Oversight Findings and Recommendations
Pursuant to clause 2(b)(1) of rule X and clause 3(c)(1) of
rule XIII, the Committee held a hearing and made findings that
are reflected in this report.
New Budget Authority, Entitlement Authority, and Tax Expenditures
Pursuant to clause 3(c)(2) of rule XIII, the Committee
finds that H.R. 801 would result in no new or increased budget
authority, entitlement authority, or tax expenditures or
revenues.
Congressional Budget Office Estimate
Pursuant to clause 3(c)(3) of rule XIII, the following is
the cost estimate provided by the Congressional Budget Office
pursuant to section 402 of the Congressional Budget Act of
1974:
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
H.R. 801 would authorize the Department of Health and Human
Services (HHS) to suspend the entry of people and goods into
the United States from certain countries if the department
determines that doing so would prevent the arrival of certain
controlled substances, including opiates and fentanyl. The bill
would require HHS to consult with the Department of Justice
before making such a determination.
Under current law, by invoking its authority under Section
362 of the Public Health Service Act, HHS can deny entry to
people or goods from certain countries to prevent the spread of
communicable diseases. Furthermore, the government may prevent
certain people (but not goods) from coming into the country if
their entry is determined to be detrimental to U.S. interests,
under Section 212(f) of the Immigration and Nationality Act.
Direct spending: Enacting H.R. 801 would expand the
government's authority to restrict the import of goods into the
United States. If that authority is used, it would result in a
net increase in direct spending because any such restrictions
would decrease the collection of certain customs fees charged
on the import of these goods. Since these fees are classified
in the budget as direct spending, any decrease in collections
would result in an increase in direct spending. A portion of
the fees collected can be spent by Customs and Border
Protection without further appropriation; therefore, the
increase in direct spending under the bill would be less than
the total change in customs fees collected.
CBO estimates that direct spending would increase by less
than $500,000 under the bill. HHS has rarely used its existing
Section 362 authority to restrict the import of goods into the
United States, and CBO's estimate incorporates the assumption
that the new authority under H.R. 801 would also be used only
rarely. However, the estimate of costs is subject to
significant uncertainty. If the new authority is not used at
all during the 2023-2033 period, H.R. 801 would have no effect
on direct spending during that period. If the authority is used
more frequently than CBO anticipates, or if an order is issued
that affects a larger number of imports than CBO expects, costs
would be larger. Additionally, if the authority under H.R. 801
is used more than CBO expects, total output of the economy
could change (through changes to international trade, for
example). CBO has not undertaken an analysis of those effects.
CBO estimates that the bill would not affect the federal
budget through immigration channels because H.R. 801 would not
expand the government's authority to restrict immigration
beyond that already authorized under the Immigration and
Nationality Act. Numerous Presidents have invoked that
authority in recent decades, most recently in Presidential
Proclamations 9645 and 9983, issued in 2017 and 2020,
respectively, which prohibited entry into the United States by
nationals of certain countries.
Spending subject to appropriation: CBO estimates that it
would cost HHS less than $500,000 to promulgate rules and
enforce orders if the agency uses the authority under the bill.
Such spending would be subject to the availability of
appropriated funds.
The CBO staff contact for this estimate is Jeremy Crimm.
The estimate was reviewed by Chad Chirico, Deputy Director of
Budget Analysis.
Phillip L. Swagel,
Director, Congressional Budget Office.
Federal Mandates Statement
The Committee adopts as its own the estimate of Federal
mandates prepared by the Director of the Congressional Budget
Office pursuant to section 423 of the Unfunded Mandates Reform
Act.
Statement of General Performance Goals and Objectives
Pursuant to clause 3(c)(4) of rule XIII, the general
performance goal or objective of this legislation is to help
stem the tide of the nation's illicit drug crisis by
restricting the import of persons and property that would
further increase the introduction of certain controlled
substances across our borders.
Duplication of Federal Programs
Pursuant to clause 3(c)(5) of rule XIII, no provision of
H.R. 801 is known to be duplicative of another Federal program,
including any program that was included in a report to Congress
pursuant to section 21 of Public Law 111-139 or the most recent
Catalog of Federal Domestic Assistance.
Related Committee and Subcommittee Hearings
Pursuant to clause 3(c)(6) of rule XIII,
1. The following hearing was used to develop or
consider H.R. 801: Joint Oversight and Investigations
Subcommittee and Health Subcommittee Field Hearing on
February 15, 2023: ``President Biden's Border Crisis is
a Public Health Crisis.''
2. The following related hearing was held on February
15, 2023: Joint Oversight and Investigations
Subcommittee and Health Subcommittee Field Hearing:
``President Biden's Border Crisis is a Public Health
Crisis.''
Committee Cost Estimate
Pursuant to clause 3(d)(1) of rule XIII, the Committee
adopts as its own the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974.
Earmark, Limited Tax Benefits, and Limited Tariff Benefits
Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the
Committee finds that H.R. 801 contains no earmarks, limited tax
benefits, or limited tariff benefits.
Advisory Committee Statement
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
Applicability to Legislative Branch
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
Section-by-Section Analysis of the Legislation
Section 1. Short title
Section 1 provides a short title of Securing the Border for
Public Health Act of 2023.
Section 2. Suspension of entries and imports from designated countries
to prevent spread of communicable diseases and import of
certain controlled substances
Section 2 amends Section 362 of the Public Health Service
Act (42 U.S.C. 265) to authorize the Secretary of the
Department of Health and Human Services, in the interest of
public health, and after consultation with the Attorney
General, to restrict the entry of persons and property from
countries designated by the Secretary when there is a
determination that introduction of certain controlled
substances into the United States would pose a serious danger.
This section defines ``certain controlled substance'' to
include, as defined in the corresponding Code of Federal
Regulations, narcotic drugs, opiates, opium derivatives,
stimulants, and fentanyl-related substances.
Changes in Existing Law Made by the Bill, as Reported
In compliance with clause 3(e) of rule XIII of the Rules of
the House of Representatives, changes in existing law made by
the bill, as reported, are shown as follows (existing law
proposed to be omitted is enclosed in black brackets, new
matter is printed in italics, and existing law in which no
change is proposed is shown in roman):
PUBLIC HEALTH SERVICE ACT
* * * * * * *
TITLE III--GENERAL POWERS AND DUTIES OF PUBLIC HEALTH SERVICE
* * * * * * *
Part G--Quarantine and Inspection
* * * * * * *
[suspension of entries and imports from designated places
[Sec. 362. Whenever the Surgeon General determines that by
reason of the existence of any communicable disease in a
foreign country there is serious danger of the introduction of
such disease into the United States, and that this danger is so
increased by the introduction of persons or property from such
country that a suspension of the right to introduce such
persons and property is required in the interest of the public
health, the Surgeon General, in accordance with regulations
approved by the President, shall have the power to prohibit, in
whole or in part, the introduction of persons and property from
such countries or places as he shall designate in order to
avert such danger, and for such period of time as he may deem
necessary for such purpose.]
SEC. 362. SUSPENSION OF ENTRIES AND IMPORTS FROM DESIGNATED COUNTRIES
TO PREVENT SPREAD OF COMMUNICABLE DISEASES AND
IMPORT OF CERTAIN CONTROLLED SUBSTANCES.
(a) In General.--Whenever the Secretary makes a determination
described in subsection (b) with respect to a country, the
Secretary, by regulation, shall have the power to prohibit, in
whole or in part, for a period of time determined to be
necessary by the Secretary, the introduction of persons and
property from such countries designated by the Secretary in
order to avert the danger described in such subsection.
(b) Determination.--A determination described in this
subsection is a determination by the Secretary that, by reason
of the existence of any communicable disease or, after
consultation with the Attorney General, certain controlled
substances in a foreign country--
(1) there is serious danger of the introduction of
such disease or substances into the United States; and
(2) such danger is so increased by the introduction
of persons or property from such country that a
suspension of the right to introduce such persons and
property is required in the interest of the public
health.
(c) Definition.--In this section, the term ``certain
controlled substance'' means--
(1) a narcotic drug as defined in section 1300.01 of
title 21, Code of Federal Regulations (or successor
regulations);
(2) an opiate as described in section 1308.11(b) or
1308.12(c) of such title (or successor regulations);
(3) an opium derivative as described in section
1308.11(c) of such title (or successor regulations);
(4) a stimulant as described in section 1308.11(f) or
1308.12(d) of such title (or successor regulations);
and
(5) a fentanyl-related substance as described in
section 1308.11(h) of such title (or successor
regulations).
* * * * * * *
Minority Views
H.R. 801 would vastly expand the authority of the Secretary
of Health and Human Services (HHS) to deny entry of people into
the United States, including those seeking legal asylum
protections, should the Secretary determine that there is a
danger of the introduction of certain controlled substances
into the U.S.
This policy amends Section 362 of the Public Health Service
Act, often referred to as ``Title 42'' authorities. Under
current law, the federal government may suspend the right to
introduce persons or property into the United States if there
is a serious danger of the introduction of a communicable
disease into the U.S.\1\ However, this legislation would vastly
expand this authority to permit the Secretary to deny entry of
persons or property into the United States should he or she
determine, after consultation with the Attorney General, that
there is a ``serious danger'' of the introduction of certain
controlled substances into the United States. While the public
health provisions under Section 362 were intended to prevent
the spread of communicable diseases in the United States, this
provision was not intended to allow the Secretary to have the
unchecked authority to deny entry of persons or property into
the country, which H.R. 801 would provide.
---------------------------------------------------------------------------
\1\42 U.S.C. 265.
---------------------------------------------------------------------------
This policy could be easily misused to inappropriately and
inhumanely block entry of immigrants and those seeking asylum
into the United States. The bill would permit the Secretary to
close U.S. borders to entrants of any country that the
Secretary may choose based on an overbroad and vague
determination that there is a ``serious danger'' of certain
controlled substances entering the United States. H.R. 801 does
not define how the Secretary should make a determination of
what constitutes a ``serious danger'' to warrant the use of
this authority, nor does the legislation provide any additional
parameters or limitations under what circumstances the
Secretary could exercise this authority, beyond simply
requiring consultation with the Attorney General.
As drafted, H.R. 801 could also be interpreted to permit
the Secretary to prohibit entry of property into the United
States through legal ports of entry, potentially blocking entry
of vital goods into the U.S. should the Secretary determine,
virtually unilaterally, that there is a serious danger of the
entry of certain controlled substances from a specific country.
This authority could be easily abused.
The federal government's law enforcement agencies,
including the Department of Justice and the Department of
Homeland Security, are best positioned to detect and divert
controlled substances at our nation's borders. Limiting entry
of controlled substances into the United States is not the role
of the Department of Health and Human Services, or our public
health agencies like the Centers for Disease Control and
Prevention.
This legislation was not subject to a hearing before the
Energy and Commerce Committee. As a result, the Committee and
the public have not had a sufficient opportunity to fully
analyze the implications for the policy. However, this
legislation could clearly have far-reaching and detrimental
consequences by vastly expanding the authority of the Secretary
to unilaterally deny entry to persons or property into the
United States.
Frank Pallone, Jr.,
Ranking Member.
[all]